ARTV

Artiva Biotherapeutics, Inc.

Biological Products, (No Diagnostic Substances)Nasdaq<br>Emerging growth company

Total Trades

Buys

Sells

Largest Trade

$100K–$500K

Insiders

Institutional Funds

Inst. Value

$1M+

Activist Filings

Insider Trades

Insider	Title	Type	Value	Shares	Price	Date
Aslan Fred	President and CEO	SELL	$15K–$50K	3K	$6.00	Dec 16, 2025
Aslan Fred	President and CEO	SELL	$15K–$50K	6K	$3.38	Nov 18, 2025
Aslan Fred	President and CEO	SELL	$100K–$500K	26K	$6.00	Oct 18, 2025

🔓Seeing ranges? Sign in for exact trade values — free forever

13F filings as of Dec 31, 2025 · 20 funds holding

Fund	Shares	Value	Type
RA CAPITAL MANAGEMENT, L.P.	9.9M	$1M+	SH
5AM Venture Management, LLC	2.4M	$1M+	SH
VR Adviser, LLC	1.6M	$1M+	SH
FRANKLIN RESOURCES INC	520K	$1M+	SH
VANGUARD GROUP INC	208K	$500K+	SH
RENAISSANCE TECHNOLOGIES LLC	116K	$100K–$500K	SH
Alyeska Investment Group, L.P.	100K	$100K–$500K	SH
GEODE CAPITAL MANAGEMENT, LLC	91K	$100K–$500K	SH
JANE STREET GROUP, LLC	41K	$100K–$500K	SH
STATE STREET CORP	36K	$100K–$500K	SH
UBS Group AG	31K	$100K–$500K	SH
MORGAN STANLEY	27K	$100K–$500K	SH
OMERS ADMINISTRATION Corp	21K	$50K–$100K	SH
GOLDMAN SACHS GROUP INC	12K	$50K–$100K	SH
WELLS FARGO & COMPANY/MN	2K	$1K–$15K	SH
BlackRock, Inc.	915	$1K–$15K	SH
BNP PARIBAS FINANCIAL MARKETS	542	$1K–$15K	SH
MARSHALL WACE, LLP	431	$1K–$15K	SH
MARK SHEPTOFF FINANCIAL PLANNING, LLC	400	$1K–$15K	SH
JPMORGAN CHASE & CO	82	<$1K	SH